Sponsored
Mike Riley, CEO of Veranova, discusses how people-first leadership, deep experience in complex chemistries, and close collaboration with customers position the CDMO to support increasingly complex modalities.
Mike Riley, Veranova
Advertisement
Articles by Mike Riley, Veranova
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What the First Factor XIa Approval Means for Developers
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
4
Drapeau’s AI Deep Dive: Qualify the Reviewer Before the AI Goes Live
5